摘要
目的探讨BiPAP呼吸机联合药物治疗慢阻肺急性发作的临床疗效。方法将60例慢阻肺急性发作患者随机分成两组,两组都采用常规的药物治疗,在此基础上治疗组加用BiPAP呼吸机治疗。结果治疗前后两组PaCO2、PaO2对比有明显差异(P<0.05)。同时治疗组治疗后PaCO2与对照组对比有显著性差异(P<0.05),而PaO2两组治疗后对比无明显差异(P>0.05)。治疗期间所有病例均能耐受机械通气与药物治疗,未见明显不良反应,两组对比无明显差异(P>0.05)。结论 BiPAP呼吸机联合药物治疗慢阻肺急性发作能显著改善血气状况,且无不良反应,值得推广应用。
Objective To investigate the clinical efficacy of BiPAP ventilation combined drug treatment for acute exacerbation of COPD. Methods 60 patients with acute exacerbation of COPD were randomly divided into two groups, both using conventional medication,on the basis of the treatment group treated with BiPAP ventilation. Results After treatment, two groups of PaCO2, PaO2 contrast were significant different （P〈0.05）. Conclusion BiPAP ventilation combined drug treatment for acute exacerbation of COPD can significantly improve blood gas status, and no adverse reactions, should be widely applied.
出处
《中国现代医药杂志》
2012年第1期69-70,共2页
Modern Medicine Journal of China
